Journal articleCancer2025
Generate shows nab-paclitaxel plus gemcitabine still an effective regimen for metastatic pancreatic cancer: In this study, mFOLFIRINOX and S-IROX did not demonstrate superior outcomes compared to GnP in patients aged 75 years or younger with metastatic pancreatic cancer.
- Journal
- Cancer
- Published
- 1 December 2025
- Citations
- 0
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try